Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis - PubMed (original) (raw)
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis
Matthew D Rutter et al. Gastroenterology. 2006 Apr.
Abstract
Background & aims: The value of colonoscopic surveillance for neoplasia in long-standing extensive ulcerative colitis remains controversial. This study reports on prospectively collected data from a surveillance program over a 30-year period.
Methods: Data were obtained from the prospective surveillance database, medical records, colonoscopy, and histology reports. The primary end point was defined as death, colectomy, withdrawal from surveillance, or census date (January 1, 2001). Follow-up information was obtained for patients who left the program.
Results: Six hundred patients underwent 2627 colonoscopies during 5932 patient-years of follow-up. The cecal intubation rate was 98.7%, with no significant complications. Seventy-four patients (12.3%) developed neoplasia, including 30 colorectal cancers (CRCs). There was no difference in median age at onset of colitis for those with or without CRC (P = .8, Mann-Whitney). The cumulative incidence of CRC by colitis duration was 2.5% at 20 years, 7.6% at 30 years, and 10.8% at 40 years. The 5-year survival rate was 73.3%. Sixteen of 30 cancers were interval cancers. CRC incidence decreased over time (r = -.40, P = .04; linear regression).
Conclusions: Colonoscopic surveillance is safe and allows the vast majority of patients to retain their colon. Although two thirds of patients with potentially life-threatening neoplasia benefited from surveillance, the program was not wholly effective in cancer prevention. The cancer incidence, however, was considerably lower than in the majority of other studies, and was constant for up to 40 years of colitis duration, suggesting there is no need to intensify surveillance over time.
Comment in
- The changing face of colorectal cancer in inflammatory bowel disease: progress at last!
Rubin DT. Rubin DT. Gastroenterology. 2006 Apr;130(4):1350-2. doi: 10.1053/j.gastro.2006.03.015. Gastroenterology. 2006. PMID: 16618426 No abstract available.
Similar articles
- Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J, Stenling R, Palmqvist R, Rutegård J. Lindberg J, et al. J Pediatr Gastroenterol Nutr. 2008 May;46(5):534-8. doi: 10.1097/MPG.0b013e31815a98ef. J Pediatr Gastroenterol Nutr. 2008. PMID: 18493208 - Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Rubin DT, et al. Gastrointest Endosc. 2007 Jun;65(7):998-1004. doi: 10.1016/j.gie.2006.09.025. Epub 2007 Apr 23. Gastrointest Endosc. 2007. PMID: 17451704 - [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. Lakatos L, et al. Orv Hetil. 2006 Jan 29;147(4):175-81. Orv Hetil. 2006. PMID: 16515026 Hungarian. - Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK. Rex DK. Am J Gastroenterol. 1995 Mar;90(3):353-65. Am J Gastroenterol. 1995. PMID: 7872270 Review. - Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Winawer SJ, et al. Gastroenterology. 2006 May;130(6):1872-85. doi: 10.1053/j.gastro.2006.03.012. Gastroenterology. 2006. PMID: 16697750 Review.
Cited by
- The current and future role of endomicroscopy in the management of inflammatory bowel disease.
Nguyen DL, Lee JG, Parekh NK, Samarasena J, Bechtold ML, Chang K. Nguyen DL, et al. Ann Gastroenterol. 2015 Jul-Sep;28(3):331-336. Ann Gastroenterol. 2015. PMID: 26130373 Free PMC article. Review. - Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis.
Gounaris E, Martin J, Ishihara Y, Khan MW, Lee G, Sinh P, Chen EZ, Angarone M, Weissleder R, Khazaie K, Barrett TA. Gounaris E, et al. Inflamm Bowel Dis. 2013 Jun;19(7):1339-45. doi: 10.1097/MIB.0b013e318281f3f8. Inflamm Bowel Dis. 2013. PMID: 23591598 Free PMC article. - Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL, Freeman TJ, Zhu J, Woodbury LG, Marincola-Smith P, Wu C, Meyer AR, Weaver CJ, Padmanabhan C, An H, Zi J, Wessinger BC, Chaturvedi R, Brown TD, Deane NG, Coffey RJ, Wilson KT, Smith JJ, Sawyers CL, Goldenring JR, Novitskiy SV, Washington MK, Shi C, Beauchamp RD. Means AL, et al. Cell Mol Gastroenterol Hepatol. 2018 May 24;6(3):257-276. doi: 10.1016/j.jcmgh.2018.05.006. eCollection 2018. Cell Mol Gastroenterol Hepatol. 2018. PMID: 30109253 Free PMC article. - Curriculum review: colorectal cancer surveillance and management of dysplasia in IBD.
Ibraheim H, Dhillon AS, Koumoutsos I, Gulati S, Hayee B. Ibraheim H, et al. Frontline Gastroenterol. 2018 Oct;9(4):271-277. doi: 10.1136/flgastro-2017-100919. Epub 2018 Feb 10. Frontline Gastroenterol. 2018. PMID: 30245789 Free PMC article. Review. - Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease.
Schulte L, Hohwieler M, Müller M, Klaus J. Schulte L, et al. Stem Cells Int. 2019 Mar 19;2019:8010645. doi: 10.1155/2019/8010645. eCollection 2019. Stem Cells Int. 2019. PMID: 31015842 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical